Related Experiment Video
Updated: Dec 18, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Neuropathological Findings in Ephedrone Encephalopathy
Yanosh Sanotsky1, Marianna Selikhova2, Ludmyla Fedoryshyn1
1Department of Neurology, Lviv Regional Clinical Hospital, Lviv, Ukraine.
Illicit ephedrone use causes severe parkinsonism-dystonia. This study reveals brain pathology, including pallidal astrogliosis and vascular damage, consistent with manganese toxicity and infection, explaining the movement disorder.
Area of Science:
- Neuroscience
- Toxicology
- Neuropathology
Background:
- Severe parkinsonism-dystonia linked to illicit ephedrone use.
- Neuropathology of ephedrone neurotoxicity remains undescribed.
Purpose of the Study:
- To conduct the first neuropathological examination of ephedrone toxicity.
- To correlate clinical symptoms with observed brain pathology.
Main Methods:
- Examined the brain of a deceased ephedrone user with parkinsonism-dystonia.
- Utilized routine stains and immunohistochemistry for neuropathological analysis.
Main Results:
- Observed diffuse pallidal astrogliosis without neuronal loss.
- Found widespread vascular pathology with foreign material occlusion and giant cell response.
- Identified a cerebellar abscess without evidence of infarction.
Conclusions:
- Clinical parkinsonism-dystonia aligns with pallidal changes and preserved tyrosine hydroxylase.
- Basal ganglia findings suggest manganese toxicity.
- Vascular pathology likely results from combined infection and ephedrone toxicity.
More Related Videos
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
12:31A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain
Published on: November 14, 2012
Related Concept Videos
Neural Regulation
Drugs Affecting Neurotransmitter Synthesis
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids